GlucoTrack, Inc. (GCTK)
Automate Your Wheel Strategy on GCTK
With Tiblio's Option Bot, you can configure your own wheel strategy including GCTK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GCTK
- Rev/Share 0.0
- Book/Share 19.5155
- PB 0.008
- Debt/Equity 0.0072
- CurrentRatio 4.8487
- ROIC -3.4549
- MktCap 4496920.0
- FreeCF/Share -33.7205
- PFCF -0.3586
- PE -0.0045
- Debt/Assets 0.0054
- DivYield 0
- ROE 3.9338
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 3
- P/B Score 5
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
Published: April 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
Next Generation AI-Driven Analytics to Unlock Key Insights from the Ongoing Continuous Blood Glucose Monitoring Clinical Study Data Next Generation AI-Driven Analytics to Unlock Key Insights from the Ongoing Continuous Blood Glucose Monitoring Clinical Study Data
Read More
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology
Read More
About GlucoTrack, Inc. (GCTK)
- IPO Date 2013-04-25
- Website https://www.glucotrack.com
- Industry Medical - Instruments & Supplies
- CEO Mr. Paul V. Goode Ph.D.
- Employees 11